![]() |
# 1888605 © BSIP/SGO | ||
| ||
DRUG DEREIMBURSEMENT
Drugs dereimbursed by the health insurance, November 2005. Exomuc, DCI : acetylcysteine, therapeutical class : mucolytic. Euphytose, therapeutical class : phytotherapy. Relvene, O-(B-hydroxyethyl)-rutosides (H.R.), therapeutical class : vascular protector. Daflon, active principle : diosmine et hesperidin, therapeutical class : vascular protector. Diosmine, therapeutical class : veinotonic and vascular protector. Mucomyst, DCI : acetylcysteine, therapeutical class : mucolytic. Diovenor, active principle : diosmine, therapeutical class : vascular protector. Rhinathiol, active principle : carbocisteine, therapeutical class : mucolytic. | ||
| Exomuc | ||
| ||
| BSIP 34, rue Villiers-de-l'Isle-Adam 75020 Paris international@bsip.com Tel 33-(0)1.43.58.69.87 | ||